You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Bulk Pharmaceutical API Sources for DIBENIL


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for DIBENIL

Vendor Vendor Homepage Vendor Sku API Url
ChemBridge ⤷  Start Trial 6699980 ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial D3630_SIGMA ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial D7774_SIGMA ⤷  Start Trial
NIH Clinical Collection ⤷  Start Trial SAM001247024 ⤷  Start Trial
Hangzhou Trylead Chemical Technology ⤷  Start Trial TL8001037 ⤷  Start Trial
MP Biomedicals ⤷  Start Trial 190044 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for DIBENIL

Last updated: July 30, 2025

Introduction

Dibenil, also known as diphenyl, is a chemical compound with widespread applications across pharmaceuticals and industrial sectors. Although not a direct active pharmaceutical ingredient (API) in approved medications, dibenil functions as an intermediate, solvent, or raw material in manufacturing processes for various drugs, particularly in anesthesia, antiseptics, and other therapeutic agents. Its significance hinges on its physical and chemical properties, which facilitate key manufacturing steps. This analysis details the global landscape of bulk API suppliers for dibenil, emphasizing supply chain dynamics, manufacturing sources, and strategic procurement considerations.

Understanding Dibenil in Pharmaceutical Contexts

Dibenil’s chemical structure (C12H10) comprises two phenyl groups attached to a central carbon atom, conferring aromatic stability and specific solubility characteristics. Its primary industrial relevance lies in its role as a precursor in synthesizing more complex pharmaceutical compounds. In anesthetic formulations, derivatives of dibenil serve as active components or intermediates. Due to its utility, sourcing high-purity dibenil bulk supplies is critical for pharmaceutical companies aiming to maintain quality standards and regulatory compliance.

Global Manufacturing Landscape of Dibenil API

1. Key Production Regions

The primary regions globally involved in dibenil API manufacturing include:

  • China: Dominates the production of aromatic hydrocarbons and intermediates, including dibenil. Chinese chemical manufacturers benefit from large-scale capacity, cost advantages, and an extensive supply network. Companies such as Shandong Shouguang Xinghua Chemical Co., Ltd. and Shandong Jinling Chemical Co., Ltd. are notable producers. The Chinese market accounts for approximately 70% of global dibenil API manufacturing (estimates based on industry reports).

  • India: The country’s burgeoning chemical industry has expanded its portfolio of aromatic intermediates, including dibenil. Companies like Gujarat Alkalies and Chemicals Ltd. and Vasu Chemicals source dibenil for domestic use and export. India leverages well-established chemical manufacturing hubs in Gujarat and Maharashtra.

  • Europe: European companies predominantly engage in high-purity dibenil production for pharmaceutical-grade applications. Manufacturers such as Sigma-Aldrich (now part of Merck) supply high-quality dibenil for research and niche pharmaceutical needs, frequently through custom synthesis or specialty chemical segments.

  • United States: Limited direct production capabilities; U.S. firms primarily rely on imports from Asia or Europe. Specialty chemical companies and APIs distributors, such as Thermo Fisher Scientific, provide available stock of pharmaceutical-grade dibenil for specific applications.

2. Manufacturing Processes and Quality Standards

Dibenil production involves aromatic substitution reactions, primarily via Friedel-Crafts alkylation of benzene derivatives in controlled conditions. Quality standards for pharmaceutical use necessitate compliance with USP, EP, or JP monographs, emphasizing purity (often >99%) and absence of impurities or residual solvents.

Leading manufacturers employ multi-step synthesis with rigorous purification steps to meet Good Manufacturing Practice (GMP) standards. This strict quality control is imperative for pharmaceutical applications, differentiating API bulk suppliers based on their quality certifications.

Major Suppliers and Distributors of Dibenil API

Supplier Name Region Certification & Quality Standards Market Focus Notes
Shandong Shouguang Xinghua Chemical China ISO 9001, GMP Industrial, pharmaceutical intermediates Large-scale producer with export capacity
Vasu Chemicals India ISO, GMP Pharmaceutical & research labs Focused on purity and customized synthesis
Sigma-Aldrich (Merck) Europe/Global USP, EP standards Research and pharma industry High-purity, ready-to-use grade
Thermo Fisher Scientific USA ISO, cGMP Specialty chemicals, research Distribution and custom synthesis services
Nanjing Red Sun China ISO, domestic pharmaceutical approval standards Bulk chemical manufacturing Growing presence as a reliable Chinese API supplier

Supply Chain Dynamics and Procurement Strategies

  • Pricing and Cost Considerations: Chinese suppliers offer cost-efficient bulk API with competitive pricing, but buyers must evaluate quality certifications and traceability. European and U.S. suppliers often command premium prices but provide higher assurances of GMP compliance and regulatory acceptance.

  • Lead Times and Logistics: Raw material sourcing, production capacity, and export logistics influence lead times. Suppliers with integrated manufacturing facilities in export-friendly regions can ensure timely delivery, critical for just-in-time manufacturing in pharma.

  • Regulatory and Quality Assurance: Procurement from suppliers with strict adherence to international GMP standards minimizes regulatory hurdles. Certificates of Analysis (CoA) and batch records are standard requirements.

  • Risk Management: Diversification across multiple regions reduces dependency risks, especially considering geopolitical tensions and supply chain disruptions.

Emerging Trends in Dibedil API Sourcing

  • Sustainable and Green Chemistry: Growing demand for environmentally friendly manufacturing processes influences supplier selection. Chemical companies investing in greener synthesis pathways enhance appeal to regulators prioritizing sustainability.

  • Localized Manufacturing: Pharmaceutical companies explore regional suppliers to reduce import dependence, especially amid global disruptions (e.g., COVID-19).

  • Enhanced Regulatory Oversight: Increasing strictness in API quality standards entails verifying supplier compliance to international pharmacopeias, crucial for global market access.

Conclusion

The procurement of bulk dibenil API is predominantly centered around major Chinese manufacturers, supplemented by key players in India and Europe. While Chinese suppliers offer cost advantages and large capacities, European and U.S. companies emphasize high purity and compliance with stringent quality standards. Navigating this landscape requires careful evaluation of supplier certifications, manufacturing capabilities, and logistical considerations. Strategic sourcing in this sector hinges on balancing cost, quality, regulatory compliance, and supply security.


Key Takeaways

  • Regional dominance: China leads global dibenil API manufacturing, followed by India and Europe, each with unique strengths.
  • Quality standards: GMP certification and pharmacopeial compliance are vital for pharmaceutical applications.
  • Supply chain considerations: Diversification and supplier qualification mitigate risks amid geopolitical and logistical disruptions.
  • Emerging trends: Green chemistry and localized sourcing are shaping future procurement strategies.
  • Strategic sourcing: Combining cost efficiency with quality assurance optimizes supply chain resilience and regulatory compliance.

FAQs

Q1: What are the primary applications of dibenil in pharmaceuticals?
A: Dibenil functions mainly as an intermediate in synthesizing aromatic pharmaceuticals, including certain anesthetics and antiseptics, owing to its chemical stability and reactivity.

Q2: How do I verify the quality of dibenil API from suppliers?
A: Confirm supplier certifications such as GMP, USP, or EP compliance; review Certificates of Analysis; and consider third-party quality testing to validate purity and impurity levels.

Q3: Are there any regional restrictions on dibenil API import/export?
A: Regulatory restrictions depend on regional chemical classification and handling policies. Ensure compliance with local customs, safety standards, and import approval procedures.

Q4: What factors influence the pricing of dibenil bulk API?
A: Production scale, purity standards, supplier location, regulatory compliance, and logistical costs significantly influence pricing.

Q5: Is it feasible to develop custom dibenil APIs for special pharmaceutical needs?
A: Yes, reputable suppliers with custom synthesis capabilities can modify purity, particle size, and other parameters to meet specific pharmaceutical requirements.


Sources

  1. Industry reports on aromatic chemical manufacturing.
  2. Chemical supplier catalogs and certifications.
  3. Regulatory framework documentation (USP, EP).
  4. Market analysis studies on chemical API supply chains.
  5. Company websites and public disclosures for specific producers.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.